Vanguard Group Inc Ocugen, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 14,772,681 shares of OCGN stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,772,681
Previous 16,683,113
11.45%
Holding current value
$15.2 Million
Previous $11.8 Million
20.97%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding OCGN
# of Institutions
112Shares Held
64.8MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$18.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$5.21 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.28 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$3.59 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X01.73MShares$1.78 Million0.12% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $223M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...